Does LIRAGLUTIDE Cause Injection site mass? 106 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 106 reports of Injection site mass have been filed in association with LIRAGLUTIDE (Victoza). This represents 0.5% of all adverse event reports for LIRAGLUTIDE.
106
Reports of Injection site mass with LIRAGLUTIDE
0.5%
of all LIRAGLUTIDE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Injection site mass From LIRAGLUTIDE?
Of the 106 reports, 4 (3.8%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Injection site mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LIRAGLUTIDE. However, 106 reports have been filed with the FAERS database.
What Other Side Effects Does LIRAGLUTIDE Cause?
Nausea (3,448)
Vomiting (1,904)
Blood glucose increased (1,531)
Diarrhoea (1,524)
Pancreatitis (1,467)
Off label use (1,133)
Decreased appetite (928)
Headache (830)
Constipation (813)
Abdominal pain upper (803)
What Other Drugs Cause Injection site mass?
EXENATIDE (3,506)
DUPILUMAB (2,243)
GLATIRAMER (2,172)
ETANERCEPT (2,101)
NALTREXONE (1,849)
TIRZEPATIDE (1,386)
LEUPROLIDE (1,359)
DULAGLUTIDE (1,319)
EVOLOCUMAB (1,254)
ADALIMUMAB (915)
Which LIRAGLUTIDE Alternatives Have Lower Injection site mass Risk?
LIRAGLUTIDE vs LISDEXAMFETAMINE
LIRAGLUTIDE vs LISDEXAMFETAMINE DIMESYLATE
LIRAGLUTIDE vs LISINOPRIL
LIRAGLUTIDE vs LISOCABTAGENE MARALEUCEL
LIRAGLUTIDE vs LITHIUM